Nestle (NSE:NEST) is sharpening its focus on its core food and beverage business, moving away from less aligned segments like health supplements, according to CEO Laurent Freixe. Speaking with the Financial Times, Freixe said the company’s foray into non-core sectors had “weakened the fabric of the organisation,” signaling a strategic course correction under his leadership.
Appointed in September 2024, Freixe emphasized that mergers and acquisitions (M&A) should not drive strategy. “M&A is not the strategy,” he stated, underscoring the importance of organic growth and market leadership. He noted that portfolio trimming would only occur in categories where Nestle lacks competitive advantage.
Despite recent headwinds, Nestle is seeing positive signs in its largest market. In an earlier interview this week, Freixe said the company is regaining market share in the U.S., even as it grapples with the impact of tariffs introduced by the Trump administration on key trading partners. These trade tensions have added complexity to the global food giant’s operations but have not derailed its renewed focus on core strengths.
The shift marks a return to fundamentals for the Swiss multinational, which has faced criticism for diluting its identity by venturing into healthcare and nutrition segments. By doubling down on its traditional food and beverage lines, Nestle aims to rebuild operational strength and investor confidence.
Freixe’s remarks come as part of a broader strategic reset intended to position Nestle for long-term stability and growth, especially in competitive global markets. The move is expected to streamline operations and reinforce Nestle’s position as a dominant player in the global consumer goods industry.


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Instagram Outage Disrupts Thousands of U.S. Users
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



